ID   LEG8_HUMAN              Reviewed;         317 AA.
AC   O00214; O15215; Q5T3P5; Q5T3Q4; Q8TEV1; Q96B92; Q9BXC8; Q9H584; Q9H585;
AC   Q9UEZ6; Q9UP32; Q9UP33; Q9UP34;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 4.
DT   03-AUG-2022, entry version 201.
DE   RecName: Full=Galectin-8 {ECO:0000303|Ref.2};
DE            Short=Gal-8;
DE   AltName: Full=Po66 carbohydrate-binding protein;
DE            Short=Po66-CBP;
DE   AltName: Full=Prostate carcinoma tumor antigen 1 {ECO:0000303|PubMed:8692978};
DE            Short=PCTA-1 {ECO:0000303|PubMed:8692978};
GN   Name=LGALS8 {ECO:0000312|HGNC:HGNC:6569};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS VAL-56 AND SER-184.
RC   TISSUE=Prostate;
RX   PubMed=8692978; DOI=10.1073/pnas.93.14.7252;
RA   Su Z.-Z., Lin J., Shen R., Fisher P.E., Goldstein N.I., Fisher P.B.;
RT   "Surface-epitope masking and expression cloning identifies the human
RT   prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene
RT   family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7252-7257(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RA   Hadari Y.R., Eisenstein M., Zakut R., Zick Y.;
RT   "Galectin-8: on the road from structure to function.";
RL   Trends Glycosci. Glycotechnol. 9:103-112(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING, AND
RP   VARIANTS TYR-19; CYS-36; VAL-56 AND SER-184.
RC   TISSUE=Lung carcinoma;
RA   Brichory F., Bidon N., Desrues B., Bourguet P., Le Pennec J.-P., Dazord L.;
RT   "Molecular cloning of a beta-galactoside-binding lectin related to
RT   galectin-8 and identified in human lung carcinoma.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS TYR-19; CYS-36; VAL-56 AND
RP   SER-184.
RA   Maier C., Haeussler J., Roesch K., Moschgath E., Vogel W.;
RT   "Genomic organization and expression of the human galectin-8 gene.";
RL   Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10980616; DOI=10.1038/sj.onc.1203767;
RA   Gopalkrishnan R.V., Roberts T., Tuli S., Kang D., Christiansen K.A.,
RA   Fisher P.B.;
RT   "Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1,
RT   a human galectin-8 related gene.";
RL   Oncogene 19:4405-4416(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RA   Lahm H., Siebert H.-C., Andre S., Hoeflich A., Diehl D., Sordat B.,
RA   Kaltner H., Wolf E., Gabius H.-J.;
RT   "Coca (colorectal carcinoma-derived) galectin-8 variant I full-length cDNA
RT   from a human colorectal carcinoma cell line.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Colon carcinoma;
RA   Lahm H., Siebert H.-C., Andre S., Hoeflich A., Diehl D., Sordat B.,
RA   Kaltner H., Wolf E., Gabius H.-J.;
RT   "Coca (Colorectal carcinoma-derived) galectin-8 variant II.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS TYR-19; CYS-36 AND
RP   VAL-56.
RA   Moisan S., Mercier J., Demers M., Belanger S.D., Alain T.,
RA   Kossakowska A.E., Potworowski E.F., St-Pierre Y.;
RT   "Galectins in murine and human non-Hodgkin's lymphomas.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   TYR-19; CYS-36; VAL-56 AND SER-184.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   INTERACTION WITH PDPN.
RX   PubMed=19268462; DOI=10.1016/j.yexcr.2009.02.021;
RA   Cueni L.N., Detmar M.;
RT   "Galectin-8 interacts with podoplanin and modulates lymphatic endothelial
RT   cell functions.";
RL   Exp. Cell Res. 315:1715-1723(2009).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CALCOCO2, AND MUTAGENESIS
RP   OF ARG-69 AND ARG-190.
RX   PubMed=22246324; DOI=10.1038/nature10744;
RA   Thurston T.L., Wandel M.P., von Muhlinen N., Foeglein A., Randow F.;
RT   "Galectin 8 targets damaged vesicles for autophagy to defend cells against
RT   bacterial invasion.";
RL   Nature 482:414-418(2012).
RN   [13]
RP   FUNCTION.
RX   PubMed=28077878; DOI=10.1038/nature21032;
RA   Staring J., von Castelmur E., Blomen V.A., van den Hengel L.G.,
RA   Brockmann M., Baggen J., Thibaut H.J., Nieuwenhuis J., Janssen H.,
RA   van Kuppeveld F.J., Perrakis A., Carette J.E., Brummelkamp T.R.;
RT   "PLA2G16 represents a switch between entry and clearance of
RT   Picornaviridae.";
RL   Nature 541:412-416(2017).
RN   [14]
RP   STRUCTURE BY NMR OF 176-317.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the C-terminal Gal-bind lectin protein from human
RT   galectin-8.";
RL   Submitted (FEB-2008) to the PDB data bank.
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) OF 1-152 IN COMPLEX WITH LACTOSE.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of N-terminal domain of human galectin-8.";
RL   Submitted (MAY-2008) to the PDB data bank.
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.33 ANGSTROMS) OF 1-154 ALONE AND IN COMPLEX WITH
RP   CARBOHYDRATES, FUNCTION, AND SUBUNIT.
RX   PubMed=21288902; DOI=10.1074/jbc.m110.195925;
RA   Ideo H., Matsuzaka T., Nonaka T., Seko A., Yamashita K.;
RT   "Galectin-8-N-domain recognition mechanism for sialylated and sulfated
RT   glycans.";
RL   J. Biol. Chem. 286:11346-11355(2011).
CC   -!- FUNCTION: Beta-galactoside-binding lectin that acts as a sensor of
CC       membrane damage caused by infection and restricts the proliferation of
CC       infecting pathogens by targeting them for autophagy (PubMed:22246324,
CC       PubMed:28077878). Detects membrane rupture by binding beta-galactoside
CC       ligands located on the lumenal side of the endosome membrane; these
CC       ligands becoming exposed to the cytoplasm following rupture
CC       (PubMed:22246324, PubMed:28077878). Restricts infection by initiating
CC       autophagy via interaction with CALCOCO2/NDP52 (PubMed:22246324,
CC       PubMed:28077878). Required to restrict infection of bacterial invasion
CC       such as S.typhimurium (PubMed:22246324). Also required to restrict
CC       infection of Picornaviridae viruses (PubMed:28077878). Has a marked
CC       preference for 3'-O-sialylated and 3'-O-sulfated glycans
CC       (PubMed:21288902). {ECO:0000269|PubMed:21288902,
CC       ECO:0000269|PubMed:22246324, ECO:0000269|PubMed:28077878}.
CC   -!- SUBUNIT: Homodimer (PubMed:21288902, Ref.15). Interacts with
CC       CALCOCO2/NDP52 (PubMed:22246324). Interacts with PDPN; the interaction
CC       is glycosylation-dependent; may participate in connection of the
CC       lymphatic endothelium to the surrounding extracellular matrix.
CC       {ECO:0000269|PubMed:21288902, ECO:0000269|PubMed:22246324,
CC       ECO:0000269|Ref.15}.
CC   -!- INTERACTION:
CC       O00214; P13798: APEH; NbExp=4; IntAct=EBI-740058, EBI-723792;
CC       O00214; Q13137: CALCOCO2; NbExp=7; IntAct=EBI-740058, EBI-739580;
CC       O00214; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-740058, EBI-10172526;
CC       O00214; Q86VP1: TAX1BP1; NbExp=4; IntAct=EBI-740058, EBI-529518;
CC       O00214; Q15583: TGIF1; NbExp=10; IntAct=EBI-740058, EBI-714215;
CC       O00214; P36406: TRIM23; NbExp=4; IntAct=EBI-740058, EBI-740098;
CC       O00214; O76024: WFS1; NbExp=3; IntAct=EBI-740058, EBI-720609;
CC       O00214; P0DTC2: S; Xeno; NbExp=2; IntAct=EBI-740058, EBI-25474821;
CC       O00214-2; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-12069522, EBI-739580;
CC       O00214-2; P27797: CALR; NbExp=3; IntAct=EBI-12069522, EBI-1049597;
CC       O00214-2; P36957: DLST; NbExp=3; IntAct=EBI-12069522, EBI-351007;
CC       O00214-2; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-12069522, EBI-10172526;
CC       O00214-2; Q96RE7: NACC1; NbExp=3; IntAct=EBI-12069522, EBI-7950997;
CC       O00214-2; Q8TDX7: NEK7; NbExp=3; IntAct=EBI-12069522, EBI-1055945;
CC       O00214-2; Q6NSM0: NR1D2; NbExp=3; IntAct=EBI-12069522, EBI-10250949;
CC       O00214-2; Q86VP1: TAX1BP1; NbExp=3; IntAct=EBI-12069522, EBI-529518;
CC       O00214-2; Q969T9: WBP2; NbExp=3; IntAct=EBI-12069522, EBI-727055;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:22246324}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:22246324}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=I;
CC         IsoId=O00214-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00214-2; Sequence=VSP_003094;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Selective expression by prostate
CC       carcinomas versus normal prostate and benign prostatic hypertrophy.
CC   -!- DOMAIN: Contains two homologous but distinct carbohydrate-binding
CC       domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51605.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD45402.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD45403.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD45404.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD45404.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAH15818.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH16486.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Galectin-8 C-terminal CRD;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_other_832";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Galectin-8 long isoform;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_other_833";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Galectin-8 long isoform;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_other_834";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L78132; AAB51605.1; ALT_INIT; mRNA.
DR   EMBL; X91790; CAA62904.1; -; mRNA.
DR   EMBL; AF074000; AAD45402.1; ALT_INIT; mRNA.
DR   EMBL; AF074001; AAD45403.1; ALT_INIT; mRNA.
DR   EMBL; AF074002; AAD45404.1; ALT_SEQ; mRNA.
DR   EMBL; AF193806; AAF19370.1; -; Genomic_DNA.
DR   EMBL; AF193805; AAF19370.1; JOINED; Genomic_DNA.
DR   EMBL; AF342815; AAK16735.1; -; mRNA.
DR   EMBL; AF342816; AAK16736.1; -; mRNA.
DR   EMBL; AF468213; AAL77076.1; -; mRNA.
DR   EMBL; AL359921; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015818; AAH15818.1; ALT_INIT; mRNA.
DR   EMBL; BC016486; AAH16486.2; ALT_INIT; mRNA.
DR   CCDS; CCDS1611.1; -. [O00214-2]
DR   CCDS; CCDS1612.1; -. [O00214-1]
DR   PIR; JC6147; JC6147.
DR   RefSeq; NP_006490.3; NM_006499.4. [O00214-2]
DR   RefSeq; NP_963837.1; NM_201543.2. [O00214-1]
DR   RefSeq; NP_963838.1; NM_201544.2. [O00214-1]
DR   RefSeq; NP_963839.1; NM_201545.2. [O00214-2]
DR   PDB; 2YRO; NMR; -; A=176-317.
DR   PDB; 2YV8; X-ray; 1.92 A; A=1-152.
DR   PDB; 2YXS; X-ray; 2.13 A; A=1-152.
DR   PDB; 3AP4; X-ray; 2.33 A; A/B/C/D=1-154.
DR   PDB; 3AP5; X-ray; 1.92 A; A=1-154.
DR   PDB; 3AP6; X-ray; 1.58 A; A/B/C/D=1-154.
DR   PDB; 3AP7; X-ray; 1.53 A; A=1-154.
DR   PDB; 3AP9; X-ray; 1.33 A; A=1-154.
DR   PDB; 3APB; X-ray; 1.95 A; A/B=1-154.
DR   PDB; 3OJB; X-ray; 3.01 A; A/B/C/D=186-315.
DR   PDB; 3VKL; X-ray; 2.55 A; A/B=1-155, A/B=184-317.
DR   PDB; 3VKM; X-ray; 2.98 A; A/B=1-155, A/B=184-317.
DR   PDB; 3VKN; X-ray; 1.98 A; A/B=1-153.
DR   PDB; 3VKO; X-ray; 2.08 A; A/B=1-153.
DR   PDB; 4BMB; X-ray; 1.35 A; A=4-153.
DR   PDB; 4BME; X-ray; 2.00 A; A/B=4-155.
DR   PDB; 4FQZ; X-ray; 2.80 A; A=1-155, A=184-317.
DR   PDB; 4GXL; X-ray; 2.02 A; A=186-317.
DR   PDB; 4HAN; X-ray; 2.55 A; A/B=1-155, A/B=184-317.
DR   PDB; 5GZC; X-ray; 1.08 A; A=7-158.
DR   PDB; 5GZD; X-ray; 1.19 A; A=7-154.
DR   PDB; 5GZE; X-ray; 1.32 A; A=7-154.
DR   PDB; 5GZF; X-ray; 2.00 A; A=1-186.
DR   PDB; 5GZG; X-ray; 2.00 A; A=1-186.
DR   PDB; 5T7I; X-ray; 2.00 A; A=1-155.
DR   PDB; 5T7S; X-ray; 1.90 A; A=1-155.
DR   PDB; 5T7T; X-ray; 1.96 A; A=1-155.
DR   PDB; 5T7U; X-ray; 1.58 A; A=1-155.
DR   PDB; 5VWG; X-ray; 2.10 A; A=1-155.
DR   PDB; 6W4Z; X-ray; 1.59 A; A/B=2-154.
DR   PDB; 6Z6Y; X-ray; 1.34 A; A=1-163.
DR   PDB; 7AEN; X-ray; 1.60 A; A/B=7-156.
DR   PDB; 7ALS; X-ray; 1.35 A; A/B=4-158.
DR   PDB; 7P1M; X-ray; 1.52 A; A/B=6-156.
DR   PDBsum; 2YRO; -.
DR   PDBsum; 2YV8; -.
DR   PDBsum; 2YXS; -.
DR   PDBsum; 3AP4; -.
DR   PDBsum; 3AP5; -.
DR   PDBsum; 3AP6; -.
DR   PDBsum; 3AP7; -.
DR   PDBsum; 3AP9; -.
DR   PDBsum; 3APB; -.
DR   PDBsum; 3OJB; -.
DR   PDBsum; 3VKL; -.
DR   PDBsum; 3VKM; -.
DR   PDBsum; 3VKN; -.
DR   PDBsum; 3VKO; -.
DR   PDBsum; 4BMB; -.
DR   PDBsum; 4BME; -.
DR   PDBsum; 4FQZ; -.
DR   PDBsum; 4GXL; -.
DR   PDBsum; 4HAN; -.
DR   PDBsum; 5GZC; -.
DR   PDBsum; 5GZD; -.
DR   PDBsum; 5GZE; -.
DR   PDBsum; 5GZF; -.
DR   PDBsum; 5GZG; -.
DR   PDBsum; 5T7I; -.
DR   PDBsum; 5T7S; -.
DR   PDBsum; 5T7T; -.
DR   PDBsum; 5T7U; -.
DR   PDBsum; 5VWG; -.
DR   PDBsum; 6W4Z; -.
DR   PDBsum; 6Z6Y; -.
DR   PDBsum; 7AEN; -.
DR   PDBsum; 7ALS; -.
DR   PDBsum; 7P1M; -.
DR   AlphaFoldDB; O00214; -.
DR   SMR; O00214; -.
DR   BioGRID; 110155; 173.
DR   IntAct; O00214; 112.
DR   MINT; O00214; -.
DR   BindingDB; O00214; -.
DR   ChEMBL; CHEMBL5475; -.
DR   DrugCentral; O00214; -.
DR   UniLectin; O00214; -.
DR   iPTMnet; O00214; -.
DR   PhosphoSitePlus; O00214; -.
DR   BioMuta; LGALS8; -.
DR   EPD; O00214; -.
DR   jPOST; O00214; -.
DR   MassIVE; O00214; -.
DR   MaxQB; O00214; -.
DR   PeptideAtlas; O00214; -.
DR   PRIDE; O00214; -.
DR   ProteomicsDB; 47785; -. [O00214-1]
DR   ProteomicsDB; 47786; -. [O00214-2]
DR   Antibodypedia; 34699; 410 antibodies from 36 providers.
DR   DNASU; 3964; -.
DR   Ensembl; ENST00000341872.10; ENSP00000342139.6; ENSG00000116977.19. [O00214-1]
DR   Ensembl; ENST00000352231.6; ENSP00000309576.2; ENSG00000116977.19. [O00214-2]
DR   Ensembl; ENST00000366584.9; ENSP00000355543.4; ENSG00000116977.19. [O00214-1]
DR   Ensembl; ENST00000450372.6; ENSP00000408657.2; ENSG00000116977.19. [O00214-2]
DR   Ensembl; ENST00000526589.5; ENSP00000435460.1; ENSG00000116977.19. [O00214-2]
DR   Ensembl; ENST00000526634.5; ENSP00000437040.1; ENSG00000116977.19. [O00214-1]
DR   Ensembl; ENST00000527974.5; ENSP00000431398.1; ENSG00000116977.19. [O00214-2]
DR   GeneID; 3964; -.
DR   KEGG; hsa:3964; -.
DR   MANE-Select; ENST00000366584.9; ENSP00000355543.4; NM_201544.4; NP_963838.1.
DR   UCSC; uc001hxw.3; human. [O00214-1]
DR   CTD; 3964; -.
DR   DisGeNET; 3964; -.
DR   GeneCards; LGALS8; -.
DR   HGNC; HGNC:6569; LGALS8.
DR   HPA; ENSG00000116977; Low tissue specificity.
DR   MIM; 606099; gene.
DR   neXtProt; NX_O00214; -.
DR   OpenTargets; ENSG00000116977; -.
DR   PharmGKB; PA30346; -.
DR   VEuPathDB; HostDB:ENSG00000116977; -.
DR   GeneTree; ENSGT00940000155727; -.
DR   InParanoid; O00214; -.
DR   OMA; LYAHRIK; -.
DR   OrthoDB; 829777at2759; -.
DR   PhylomeDB; O00214; -.
DR   TreeFam; TF315551; -.
DR   PathwayCommons; O00214; -.
DR   SignaLink; O00214; -.
DR   BioGRID-ORCS; 3964; 10 hits in 1085 CRISPR screens.
DR   ChiTaRS; LGALS8; human.
DR   EvolutionaryTrace; O00214; -.
DR   GeneWiki; Galectin-8; -.
DR   GeneWiki; LGALS8; -.
DR   GenomeRNAi; 3964; -.
DR   Pharos; O00214; Tchem.
DR   PRO; PR:O00214; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O00214; protein.
DR   Bgee; ENSG00000116977; Expressed in sperm and 198 other tissues.
DR   ExpressionAtlas; O00214; baseline and differential.
DR   Genevisible; O00214; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IDA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IDA:GO_Central.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0098586; P:cellular response to virus; IMP:UniProtKB.
DR   GO; GO:1904977; P:lymphatic endothelial cell migration; IDA:UniProtKB.
DR   GO; GO:0098792; P:xenophagy; IMP:UniProtKB.
DR   CDD; cd00070; GLECT; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR044156; Galectin-like.
DR   InterPro; IPR030638; Galectin_8.
DR   InterPro; IPR001079; Galectin_CRD.
DR   PANTHER; PTHR11346; PTHR11346; 1.
DR   PANTHER; PTHR11346:SF22; PTHR11346:SF22; 1.
DR   Pfam; PF00337; Gal-bind_lectin; 2.
DR   SMART; SM00908; Gal-bind_lectin; 2.
DR   SMART; SM00276; GLECT; 2.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   PROSITE; PS51304; GALECTIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autophagy; Cytoplasm;
KW   Cytoplasmic vesicle; Lectin; Reference proteome; Repeat.
FT   CHAIN           1..317
FT                   /note="Galectin-8"
FT                   /id="PRO_0000076943"
FT   DOMAIN          19..152
FT                   /note="Galectin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00639"
FT   DOMAIN          187..317
FT                   /note="Galectin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00639"
FT   BINDING         69
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:21288902"
FT   BINDING         79
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:21288902"
FT   BINDING         89
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:21288902"
FT   BINDING         249..255
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /evidence="ECO:0000250"
FT   SITE            59
FT                   /note="Critical for binding to sialylated and sulfated
FT                   oligosaccharides"
FT                   /evidence="ECO:0000269|PubMed:21288902"
FT   VAR_SEQ         183
FT                   /note="L -> LPSNRGGDISKIAPRTVYTKSKDSTVNHTLTCTKIPPMNYVSK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3,
FT                   ECO:0000303|Ref.7, ECO:0000303|Ref.8"
FT                   /id="VSP_003094"
FT   VARIANT         19
FT                   /note="F -> Y (in dbSNP:rs1126407)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.8"
FT                   /id="VAR_012990"
FT   VARIANT         36
FT                   /note="R -> C (in dbSNP:rs1041935)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.8"
FT                   /id="VAR_009710"
FT   VARIANT         56
FT                   /note="M -> V (in dbSNP:rs1041937)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8692978, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.8"
FT                   /id="VAR_012991"
FT   VARIANT         184
FT                   /note="R -> S (in dbSNP:rs2243525)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8692978, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_063506"
FT   MUTAGEN         69
FT                   /note="R->H: Abolishes localization to cytoplasmic vesicles
FT                   in case of infection by S.typhimurium."
FT                   /evidence="ECO:0000269|PubMed:22246324"
FT   MUTAGEN         190
FT                   /note="R->H: Does not affect localization to cytoplasmic
FT                   vesicles in case of infection by S.typhimurium."
FT                   /evidence="ECO:0000269|PubMed:22246324"
FT   CONFLICT        14
FT                   /note="N -> S (in Ref. 8; AAL77076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        98..100
FT                   /note="KRE -> QKEK (in Ref. 2; CAA62904)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="D -> A (in Ref. 2; CAA62904)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171
FT                   /note="S -> V (in Ref. 1; AAB51605)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="R -> G (in Ref. 8; AAL77076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="K -> Q (in Ref. 1; AAB51605)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        225
FT                   /note="D -> H (in Ref. 8; AAL77076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="F -> L (in Ref. 7; AAK16736)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..6
FT                   /evidence="ECO:0007829|PDB:4FQZ"
FT   STRAND          9..14
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          17..22
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          32..38
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          44..53
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   TURN            56..59
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:3VKL"
FT   STRAND          75..82
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          102..109
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          111..118
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          121..127
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   HELIX           132..134
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          137..143
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   STRAND          145..152
FT                   /evidence="ECO:0007829|PDB:5GZC"
FT   HELIX           155..158
FT                   /evidence="ECO:0007829|PDB:6Z6Y"
FT   STRAND          186..190
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          200..207
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          213..220
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   TURN            221..224
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          225..233
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   TURN            234..237
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          238..245
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          246..249
FT                   /evidence="ECO:0007829|PDB:3VKL"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:3OJB"
FT   STRAND          266..273
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          275..282
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          285..291
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   HELIX           297..299
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   STRAND          302..317
FT                   /evidence="ECO:0007829|PDB:4GXL"
FT   CONFLICT        O00214-2:220
FT                   /note="M -> T (in Ref. 8; AAL77076)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   317 AA;  35808 MW;  AA13116AC5C0D69A CRC64;
     MMLSLNNLQN IIYNPVIPFV GTIPDQLDPG TLIVIRGHVP SDADRFQVDL QNGSSMKPRA
     DVAFHFNPRF KRAGCIVCNT LINEKWGREE ITYDTPFKRE KSFEIVIMVL KDKFQVAVNG
     KHTLLYGHRI GPEKIDTLGI YGKVNIHSIG FSFSSDLQST QASSLELTEI SRENVPKSGT
     PQLRLPFAAR LNTPMGPGRT VVVKGEVNAN AKSFNVDLLA GKSKDIALHL NPRLNIKAFV
     RNSFLQESWG EEERNITSFP FSPGMYFEMI IYCDVREFKV AVNGVHSLEY KHRFKELSSI
     DTLEINGDIH LLEVRSW
//
